Anti-VEGF Approval and Retinal Photocoagulation for Retinopathy of Prematurity
This cohort study examines the association between regulatory approval of anti–vascular endothelial growth factor (anti-VEGF) therapy and the use of retinal photocoagulation vs anti-VEGF therapy to treat retinopathy of prematurity in infants in Japan.
Authors
- Masahiro Akada (ORCID: https://orcid.org/0009-0005-4603-7444)
- Masahiro Miyake (ORCID: https://orcid.org/0000-0001-7410-3764)
- Hiroshi Tamura (ORCID: https://orcid.org/0000-0002-7740-2732)
- Yoko Fukushima (ORCID: https://orcid.org/0000-0001-7909-7332)
- Masayuki Hata (ORCID: https://orcid.org/0000-0001-6400-9029)
- Akitaka Tsujikawa (ORCID: https://orcid.org/0000-0001-5506-0412)
Institutions
- Kyoto University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- JAMA Ophthalmology
- Published
- 2025-09-18
- DOI
- https://doi.org/10.1001/jamaophthalmol.2025.2948
- Citations
- 1
- Primary Topic
- Retinopathy of Prematurity Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.36